Amalgamated Bank Eq Rx, Inc. Transaction History

Amalgamated Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$1.66 - $2.31 $7,953 - $11,067	4,791 Added 18.16%	31,178 $69,000
Q2 2023 Aug 11, 2023	BUY	$1.61 - $1.96 $8,578 - $10,442	5,328 Added 25.3%	26,387 $49,000
Q1 2023 May 02, 2023	SELL	$1.8 - $2.83 $8,838 - $13,895	-4,910 Reduced 18.91%	21,059 $41,000
Q3 2022 Nov 09, 2022	BUY	$0.94 - $5.99 $8,132 - $51,825	8,652 Added 49.96%	25,969 $129,000
Q2 2022 Aug 15, 2022	BUY	$3.2 - $5.69 $55,414 - $98,533	17,317 New	17,317 $81,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.